Vinorelbine and disease progression Patient Reports February 12, 2012

Vinorelbine Side Effects Report #5151044-6
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Female patient, weighting 123.0 lb, was diagnosed with vulval cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: disease progression. Vinorelbine dosage: 20 MG/M2 D 1,8, 15 Q 28 D IV. During the same period patient was treated with VINORELBINE TARTRATE, VINORELBINE TARTRATE, LAPATINIB. Patient died on 10/31/2006.

Vinorelbine Side Effects Report #5774892-8
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, weighting 173.7 lb, was diagnosed with transitional cell carcinoma and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: disease progression, lung neoplasm, pleural effusion, pulmonary embolism , pulmonary mass. Vinorelbine dosage: 49 MG D1,D8,D15/CYCLE 042. During the same period patient was treated with LAPATINIB, VYTORIN, LISINOPRIL, ATENOLOL. Patient died on 06/08/2008.

Vinorelbine Side Effects Report #5775229-0
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, weighting 198.0 lb, was diagnosed with synovial sarcoma and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: circulatory collapse, dehydration, disease progression, dyspnoea, hypertension, metastases to lung, metastases to trachea, nausea , oral intake reduced. Vinorelbine dosage: 15MG/M2 (INITIALLY 25 D 1,8,15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient died on 06/05/2008.

Vinorelbine Side Effects Report #5028579-X
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on June 16, 2006. Male patient, weighting 186.5 lb, was diagnosed with pancreatic carcinoma and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: disease progression. Vinorelbine dosage: 30 MG M2= 63 MG WEEKLY IVP. Patient died on 05/21/2006.


Vinorelbine Side Effects Report #5014600-1
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: disease progression, neutropenia. Vinorelbine dosage: 30 MG/M**2. Patient recovered.

Vinorelbine Side Effects Report #5732775-3
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Female patient, weighting 100.0 lb, was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, performance status decreased. Vinorelbine dosage: 25 MG/M2 D 1,8,15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient died on 04/08/2008.